Clinical study of tolerance and effectiveness of a F (ab') 2 polyvalent antienom for African snake bites in Kindia, Guinea;Étude clinique de la tolérance et de l'efficacité d'un sérum anti-ophidien polyvalent F (ab') 2 pour l'Afrique a Kindia, Guinée

Bulletin de la Societe de Pathologie Exotique

Volumn 105, Issue 3, 2012, Pages 157-161

  Balde M C ^a   Chippaux, J P ^b   Boiro, M Y ^a   Stock, R ^c   Massougbodji, A ^d  

^a Institut Pasteur de Guinée IPG   (Guinea)

^b IRD et Université Paris Descartes   (Benin)

^c INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

^d UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

Antivenom; Antivipmyn ; Consultation; Envenomation; Guinea; Patient; Snake; Sub Saharan Africa

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; SNAKE VENOM; VENOM ANTISERUM;

ADOLESCENT; ADULT; AGED; ANIMAL; ARTICLE; CHILD; CLINICAL TRIAL; DELAYED DIAGNOSIS; FEMALE; GUINEA; HUMAN; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PHASE 4 CLINICAL TRIAL; PRESCHOOL CHILD; SNAKEBITE; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIVENINS; CHILD; CHILD, PRESCHOOL; DELAYED DIAGNOSIS; FEMALE; GUINEA; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INFANT; MALE; MIDDLE AGED; SNAKE BITES; SNAKE VENOMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865185654     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13149-012-0223-3     Document Type: Article

References (14)

1. Baldé MC, Camara AMB, Koivogui A, Camara SK (2005) Les envenimations de la préfecture de Kindia traitées a l'Institut Pasteur de Guinée durant un an (2003-2004). Bull Soc Pathol Exot 98 (4):285-6 [http://www.pathexo.fr/documents/articlesbull/T98-4-2752-3-2p.pdf] (Pubitemid 43041567)
2. Baldé MC, Dieng B, Kondé K (2000) Quelques cas de morsures de serpents recus a l'IRBAG (1980-1990). Ann IRBAG 3:6-12
3. Baldé MC, Dieng B, Inapogui AP, et al (2002) Problématique des envenimations en Guinée. Bull Soc Pathol Exot 95 (3):157-9 [http://www.pathexo.fr/documents/articles-bull/T95-3-Env7.pdf]
4. Boulain JC, Ménez A (1982) Neurotoxin-specific immunoglobulins accelerate dissociation of the neurotoxin-acetylcholine receptor complex. Science 217 (4561):732-3 (Pubitemid 12049573)
5. Chippaux JP (1998) The development and use of immunotherapy in Africa. Toxicon 36 (11):1503-6
6. Chippaux JP (2002) The treatment of snake bites: analysis of requirements and assessment of therapeutic efficacy in tropical Africa. In: Perspectives in molecular toxinology. A Ménez (ed) John Wiley & Sons, Ltd Chichester, pp 457-72
7. Chippaux JP, Amadi-Eddine S, Fagot P (1998) Validité d'un test de diagnostic et de surveillance du syndrome hémorragique lors des envenimations vipérines en Afrique sub-saharienne. Med Trop 58:369-71 (Pubitemid 128508952)
8. Chippaux JP, Amadi-Eddine S, Fagot P (1999) Diagnostic et surveillance des hémorragies dues aux envenimations vipérines en savane africaine. Bull Soc Pathol Exot 92 (2):109-13
9. Chippaux JP, Lang J, Amadi-Eddine S, et al (1998) Clinical safety of a polyvalent F (ab')2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators. Trans R Soc Trop Med Hyg 92 (6):657-62 (Pubitemid 29015222)
10. Chippaux JP, Lang J, Amadi-Eddine S, et al (1999) Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F (ab)2: results of a clinical trial in northern Cameroon. Am J Trop Med Hyg 61 (6):1017-8 (Pubitemid 30084131)
11. Chippaux JP, Massougbodji A, Stock RP, et al (2007) Clinical trial of a F (ab')2 polyvalent equine antivenom for African snakebites in Benin. Am J Trop Med Hyg 77 (3):538-46 (Pubitemid 351844333)
12. Ramos-Cerrillo B, de Roodt AR, Chippaux JP, et al (2008) Characterization of a new polyvalent antivenom (Antivipmyn® Africa) against African vipers and elapids. Toxicon 52 (8):881-8. Epub 2008 Sep 27
13. Stock RP, Massougbodji A, Alagon A, Chippaux JP (2007) Bringing antivenom to Sub-Saharan Africa. Nat Biotechnol 25 (2):173-7
14. Theakston RD, Warrell DA, Griffiths E (2003) Report of a WHO workshop on the standardization and control of antivenoms. Toxicon 41 (5):541-57 (Pubitemid 36379293)